Glass House Brands Subordinate Voting Shares (GLAS) vs Orchestra BioMed (OBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Orchestra BioMed (OBIO) has outperformed Glass House Brands Subordinate Voting Shares (GLAS) over the past year, gaining 107.3% versus a loss of 36.7%. Over five years, GLAS leads with a +2.7% price change compared with -42.5% for OBIO. Glass House Brands Subordinate Voting Shares is the larger company by market cap ($401.0 million vs $342.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GLAS | OBIO |
|---|---|---|
| Share price | $4.26 | $5.69 |
| Market cap | $401.00M | $342.00M |
| 1-day change | -17.06% | +0.53% |
| YTD return | -42.03% | +36.39% |
| 1-year return | -36.67% | +107.33% |
| 5-year return | +2.70% | -42.54% |
| Forward P/E | 18.91 | — |
| EPS (TTM) | $-0.74 | $-0.86 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.93 | $6.50 |
| 52-week low | $4.22 | $2.78 |
| Distance from 52-week high | -69.45% | -12.46% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +276.03% | +118.45% |
| Average volume | 736.52K | 299.24K |
| Shares outstanding | 88.00M | 60.11M |
| Employees | 357 | 86 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OBIO has outperformed GLAS by 144.0 percentage points over the past year.
About Glass House Brands Subordinate Voting Shares
GLAS stock →Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.
Health Care · Medicinal Chemicals and Botanical Products · 357 employees
About Orchestra BioMed
OBIO stock →Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States.
Health Care · Medicinal Chemicals and Botanical Products · 86 employees
GLAS vs OBIO FAQ
Which is bigger, Glass House Brands Subordinate Voting Shares or Orchestra BioMed?
Glass House Brands Subordinate Voting Shares (GLAS) is larger, with a market capitalization of $401.00M compared with $342.00M for Orchestra BioMed (OBIO).
Which stock has performed better over the past year, GLAS or OBIO?
OBIO returned +107.33% over the past 12 months, compared with -36.67% for GLAS (price return, excluding dividends). Past performance does not predict future results.
Are Glass House Brands Subordinate Voting Shares and Orchestra BioMed in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.